what bmi for glp-1 GLP‑1 real‑world data obesity: A new standard for metabolic care The Promise of Injectable GLP-1

These medications slow gastric emptying and reduce appetite, which can inadvertently decrease fluid intake while increasing the risk of dehydration through gastrointestinal symptoms like nausea, vomiting, and diarrhea

Patients taking a GLP-1 agonist, are advised to make sure they inform their healthcare team including the anaesthetist about their medicine prior to a surgical procedure

And for those preferring oral medication, Oral Wegovy, as well as Foundayo, provide needle-free alternatives

Compounded oral drops are produced in FDA-compliant compounding pharmacies but are not FDA-approved as a specific formulation